Phase I study of BAY 73-4506, an inhibitor of oncogenic and angiogenic kinases, in patients with advanced refractory colorectal carcinoma (CRC).
暂无分享,去创建一个
M. Büchert | D. Strumberg | M. Scheulen | R. Heinig | K. Mross | A. Frost | U. Fasol | O. Christensen | A. Wagner